Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2009 2
2010 4
2011 1
2012 6
2013 3
2014 4
2015 7
2016 6
2017 4
2018 3
2019 6
2020 9
2021 5
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Cu(I) Coordination Compounds Conjugated to Au Nanorods for Future Applications in Drug Delivery: Insights in Molecular, Electronic and Cu Local Structure in Solid and Liquid Phase.
Lopez A, Amatori S, Olivieri E, Venditti I, Iucci G, Meneghini C, Bertelà F, Del Bello F, Quaglia W, Pellei M, Santini C, Battocchio C. Lopez A, et al. Among authors: del bello f. Chemphyschem. 2024 Mar 22:e202400074. doi: 10.1002/cphc.202400074. Online ahead of print. Chemphyschem. 2024. PMID: 38517325
Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators.
Baldassarri C, Giorgioni G, Piergentili A, Quaglia W, Fontana S, Mammoli V, Minazzato G, Marangoni E, Gasparrini M, Sorci L, Raffaelli N, Cappellacci L, Petrelli R, Del Bello F. Baldassarri C, et al. Among authors: del bello f. Pharmaceuticals (Basel). 2023 Jan 27;16(2):189. doi: 10.3390/ph16020189. Pharmaceuticals (Basel). 2023. PMID: 37259338 Free PMC article.
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.
Bonifazi A, Del Bello F, Giorgioni G, Piergentili A, Saab E, Botticelli L, Cifani C, Micioni Di Bonaventura E, Micioni Di Bonaventura MV, Quaglia W. Bonifazi A, et al. Among authors: del bello f. Med Res Rev. 2023 Sep;43(5):1607-1667. doi: 10.1002/med.21959. Epub 2023 Apr 10. Med Res Rev. 2023. PMID: 37036052 Review.
Investigating the role of the central melanocortin system in stress and stress-related disorders.
Micioni Di Bonaventura E, Botticelli L, Del Bello F, Giorgioni G, Piergentili A, Quaglia W, Romano A, Gaetani S, Micioni Di Bonaventura MV, Cifani C. Micioni Di Bonaventura E, et al. Among authors: del bello f. Pharmacol Res. 2022 Nov;185:106521. doi: 10.1016/j.phrs.2022.106521. Epub 2022 Oct 20. Pharmacol Res. 2022. PMID: 36272641 Free article. Review.
Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma.
Pavletić P, Semeano A, Yano H, Bonifazi A, Giorgioni G, Piergentili A, Quaglia W, Sabbieti MG, Agas D, Santoni G, Pallini R, Ricci-Vitiani L, Sabato E, Vistoli G, Del Bello F. Pavletić P, et al. Among authors: del bello f. J Med Chem. 2022 Sep 22;65(18):12124-12139. doi: 10.1021/acs.jmedchem.2c00840. Epub 2022 Sep 13. J Med Chem. 2022. PMID: 36098685 Free PMC article.
Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects.
Del Bello F, Pellei M, Bagnarelli L, Santini C, Giorgioni G, Piergentili A, Quaglia W, Battocchio C, Iucci G, Schiesaro I, Meneghini C, Venditti I, Ramanan N, De Franco M, Sgarbossa P, Marzano C, Gandin V. Del Bello F, et al. Inorg Chem. 2022 Mar 28;61(12):4919-4937. doi: 10.1021/acs.inorgchem.1c03658. Epub 2022 Mar 14. Inorg Chem. 2022. PMID: 35285628 Free PMC article.
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor.
Giorgioni G, Del Bello F, Quaglia W, Botticelli L, Cifani C, Micioni Di Bonaventura E, Micioni Di Bonaventura MV, Piergentili A. Giorgioni G, et al. Among authors: del bello f. J Med Chem. 2022 Feb 24;65(4):3098-3118. doi: 10.1021/acs.jmedchem.1c02191. Epub 2022 Feb 14. J Med Chem. 2022. PMID: 35157454 Free PMC article. Review.
Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3 Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders.
Bonifazi A, Newman AH, Keck TM, Gervasoni S, Vistoli G, Del Bello F, Giorgioni G, Pavletić P, Quaglia W, Piergentili A. Bonifazi A, et al. Among authors: del bello f. ACS Chem Neurosci. 2021 Oct 6;12(19):3638-3649. doi: 10.1021/acschemneuro.1c00368. Epub 2021 Sep 16. ACS Chem Neurosci. 2021. PMID: 34529404 Free PMC article.
68 results